Iodoarene-mediated one-pot preparation of 2,5-disubstituted and 2,4,5-trisubstituted oxazoles from alkyl aryl ketones with oxone in nitriles
作者:Yoshihide Ishiwata、Hideo Togo
DOI:10.1016/j.tet.2009.09.109
日期:2009.12
aryliodonium I(III) species reacts with alkylaryl ketone to generate β-keto iodonium species. Then, β-keto iodonium species reacts with nitrile to produce the corresponding oxazole. In principle, iodoarene works as a catalyst. However, 1 equiv of iodoarene is required because 1 equiv of reactive aryliodonium I(III) species must be formed before the reaction with alkylaryl ketone.
Direct Synthesis of 2,5-Disubstituted Oxazoles through an Iodine-Catalyzed Decarboxylative Domino Reaction
作者:Wei Xu、Ulrich Kloeckner、Boris J. Nachtsheim
DOI:10.1021/jo400753n
日期:2013.6.21
An efficient iodine-catalyzed synthesis of highly substituted oxazoles is presented. Starting from readily available aryl methylketones, β-keto esters, or styrenes, in combination with α-amino acids as amine-containing coupling partners, the corresponding 2-alkyl-5-aryl- substituted oxazoles were obtained in up to 80% yield via a decarboxylative domino reaction.
Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
申请人:Collins James Ian
公开号:US20080070895A1
公开(公告)日:2008-03-20
Compounds of formula I are disclosed:
in which X is a 5-membered heteroaryl ring and R is as defined herein. The compounds are inhibitors of the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease.
A novel and direct synthesis of 2-alkyl-5-aryl disubstituted oxazoles
作者:Jong Chan Lee、Taiyoung Hong
DOI:10.1016/s0040-4039(97)10362-8
日期:1997.12
A direct and efficient method for the preparation of 2-alkyl-5-aryl disubstituted oxazoles was realized by reaction of aromatic alpha-methyl ketones with various aliphatic nitriles in the presence of Tl(OTf)(3). (C) 1997 Elsevier Science Ltd.
Sulphamides for Treatment of Cancer
申请人:Lewis Huw David
公开号:US20090197904A1
公开(公告)日:2009-08-06
Bridged bicyclic sulphamides of formula (I) are disclosed for treatment of cancer.